DEA Extends Ban on Four Synthetic Drugs for More Study Time
Published Date: 12/16/2025
Rule
Summary
The DEA is extending the temporary ban on four risky substances—4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA—keeping them in the strictest drug category (Schedule I) for another year. This means anyone making, selling, or using these chemicals faces serious legal rules and penalties until a permanent decision is made. The extension runs from December 12, 2025, to December 12, 2026, or sooner if a final rule is set.
Analyzed Economic Effects
4 provisions identified: 0 benefits, 4 costs, 0 mixed.
Temporary Schedule I Status Extended One Year
The DEA extends temporary Schedule I control of four synthetic cannabinoids — 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA — from December 12, 2025 through December 12, 2026, or until a final scheduling rule takes effect. The extension also covers their salts, isomers, and salts of isomers.
Businesses Making or Selling Face Continued Liability
If you manufacture, distribute, reverse-distribute, import, or export these four substances, you remain subject to the regulatory controls and the administrative, civil, and criminal sanctions that apply to Schedule I controlled substances for the period December 12, 2025 to December 12, 2026. The order explicitly lists those handling activities as covered.
Users and Possessors Remain Subject to Penalties
If you possess or use 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, or MMB-FUBICA (including their salts and isomers), the administrative, civil, and criminal sanctions for Schedule I substances remain in effect from December 12, 2025 through December 12, 2026. The temporary order continues penalties for possession and use.
Researchers and Laboratories—Controls Continue
If you engage in research, instructional activities, or chemical analysis with these four substances, you continue to be subject to Schedule I controls and the associated administrative, civil, and criminal sanctions during the extension period (December 12, 2025 to December 12, 2026). The order covers research and instructional activities explicitly.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-16665, Exempt Chemical Preparations Under the Controlled Substances Act
The applications for exempt chemical preparations received by the Drug Enforcement Administration between March 1, 2026, and June 30, 2026, as listed below, were accepted for filing and have been approved or denied as indicated. This publication addresses preparations through June 30, 2026, that were not included in previous Federal Register notices, and it does not affect preparations that have been previously published.
2026-16413, Schedules of Controlled Substances: Temporary Placement of O-Desmethyltramadol in Schedule I
The Drug Enforcement Administration issues this temporary order to schedule O-desmethyltramadol (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2-[(dimethylamino)methyl]-1- hydroxycyclohexyl]phenol), including its isomers, esters, ethers, salts, and salts of isomers, esters and ethers, in schedule I of the Controlled Substances Act. DEA bases this action on a finding that placing O-DSMT in schedule I is necessary to avoid an imminent hazard to public safety. This order imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle O-DSMT.
2026-16375, Schedules of Controlled Substances: Rescheduling of Suvorexant, Lemborexant, and Daridorexant From Schedule IV Into Schedule V
The Drug Enforcement Administration proposes to transfer suvorexant ([(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4- diazepan-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone), lemborexant ((1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)- N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide), and daridorexant ([(2S)-2-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-2-methylpyrrolidin-1- yl]-[5-methoxy-2-(triazol-2-yl)phenyl]methanone) from schedule IV to schedule V of the Controlled Substances Act. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule V controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle suvorexant, lemborexant, and daridorexant.
2026-15624, Amendment to 3,4-MDP-2-P Methyl Glycidic Acid, a List I Chemical
The Drug Enforcement Administration is proposing to modify the listing of the list I chemical 3,4-MDP-2-P methyl glycidic acid (also known as PMK glycidic acid) to include esters of 3,4-MDP-2-P methyl glycidic acid, not listed elsewhere in the Controlled Substances Act (CSA), as list I chemicals under the CSA. The current listing of 3,4- MDP-2-P methyl glycidic acid includes its salts, optical and geometric isomers, and salts of isomers. DEA proposes the new listing to read as follows: 3,4-MDP-2-P methyl glycidic acid (PMK glycidic acid) and its esters, not listed elsewhere in the CSA, its optical and geometric isomers, its salts, salts of its optical and geometric isomers, salts of its esters, not listed elsewhere in the CSA, and any combination thereof, whenever the existence of such is possible.
Previous / Next Documents
Previous: 2025-22957, Safety Zone; Fireworks Display, Lower Mississippi River, Natchez, MS
On December 31, 2025, from 6 to 7 p.m., the Coast Guard will block off a part of the Lower Mississippi River near Natchez, MS, to keep everyone safe during a fireworks show on a barge. Boats and people can’t enter this zone unless they get special permission. This quick safety move helps prevent accidents and keeps the river safe without costing anyone extra.
Next: 2025-22961, 2025 Quarterly Listings; Second Quarter; Safety Zones, Security Zones, and Special Local Regulations
The Coast Guard is letting everyone know about temporary safety and security rules they put in place between April and June 2025 that expired before being officially published. These rules affect boaters, event organizers, and waterfront users by setting up safety zones and special event regulations to keep everyone safe. While these rules didn’t hit the Federal Register on time, the Coast Guard made sure people were informed through local alerts and patrols—no surprise fees or penalties here!